The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen

International Journal of Cancer

Volumn 70, Issue 3, 1997, Pages 349-356

  Uyttenhove, Catherine ^a   Godfraind, Catherine ^a   Lethé, Bernard ^a   Amar Costesec, Alain ^b   Renauld, Jean Christophe ^a   Gajewski, Thomas F ^a   Duffour, Marie Thérèse ^c   Warnier, Guy ^a   Boon, Thierry ^a   Van Den Eynde, Benoît J ^a,d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b International Institute of Cellular and Molecular Pathology   (Belgium)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TESTIS; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; FEMALE; LEUKEMIA L1210; MALE; MAST-CELL SARCOMA; MICE; MICE, INBRED DBA; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; SEX FACTORS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPERMATOGONIA; T-LYMPHOCYTES, CYTOTOXIC; TESTIS;

EID: 0031045863     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.0.CO;2-A     Document Type: Article

References (30)

1. AMAR-COSTESEC, A., GODELAINE, D., VAN DEN EYNDE, B. and BEAUFAY, H., Identification and characterization of the tumor-specific P1A gene product. Biol. Cell, 81, 195-203 (1994).
2. BARKER, C.F. and BILLINGHAM, R.E., Immunologically privileged sites. Advanc. Immunol., 25, 1-54 (1977).
3. BELLGRAU, D., GOLD, D., SELAWRY, H., MOORE, J., FRANZUSOFF, A. and DUKE, R.C., A role for CD95 ligand in preventing graft rejection. Nature (London), 377, 630-632 (1995).
4. BLOOM, W. and FAWCETT, D.W., A textbook of histology, 11th ed., pp. 833-834, Saunders, Philadelphia (1986).
5. BOËL, P., WILDMANN, C., SENSI, M.-L., BRASSEUR, R., RENAULD, J.-C., COULIE, P., BOON, T. and VAN DER BRUGGEN, P., BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167-175 (1995).
6. BOON, T., CEROTTINI, J.-C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994a).
7. BOON, T., VAN DEN EYNDE, B., HIRSCH, H., MORONI, C., DE PLAEN, E., VAN DER BRUGGEN, P., DE SMET, C., LURQUIN, C., SZIKORA, J.-P. and DE BACKER, O., Genes coding for tumor-specific rejection antigens. Cold Spring Harbor Symposia on Quantitative Biology: molecular genetics of cancer. Vol. 59, pp. 617-622, Cold Spring Harbor Press, Cold Spring Harbor, NY (1994b).
8. BOON, T., VAN SNICK, J., VAN PEL, A., UYTTENHOVE, C. and MARCHAND, M., Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J. exp. Med., 152, 1184-1193 (1980).
9. BRICHARD, V.G., WARNIER, G., VAN PEL, A., MORLIGHEM, G., LUCAS, S. and BOON, T., Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815. Europ. J. Immunol., 25, 664-671 (1995).
10. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J. and RUTTER, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299 (1979).
11. DE PLAEN, E., ARDEN, K., TRAVERSARI, C., GAFORIO, J.J., SZIKORA, J.-R, DE SMET, C., BRASSEUR, F., VAN DER BRUGGEN, P., LETHÉ, B., LURQUIN, C., BRASSEUR, R., CHOMEZ, P., DE BACKER, O., CAVENEE, W. and BOON, T., Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
12. GAJEWSKJ, T.F., FALLARINO, F., UYTTENHOVE, C. and BOON, T., Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol., 156, 2909-2917 (1996).
13. GAJEWSKI, T.F., RENAULD, J.-C., VAN PEL, A. and BOON, T., Co-stimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine anti-tumor cytolytic T lymphocytes in vitro. J. Immunol., 154, 5637-5648 (1995).
14. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHE, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. exp. Med., 179, 921-930 (1994).
15. HAAS, G.G., JR., D'CRUZ, O.J. and DE BAULT, L.E., Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Amer. J. reprod. Immunol. Microbiol., 18, 47-51 (1988).
16. HUNT, J.S., Immunobiology of pregnancy. Curr. Opin. Immunol., 4, 591-596 (1992).
17. LETHÉ, B., VAN DEN EYNDE, B., VAN PEL, A., CORRADIN, G. and BOON, T., Mouse tumor rejection antigens P815A and P815B : two epitopes carried by a single peptide. Europ. J. Immunol., 22, 2283-2288 (1992).
18. MARCHAND, M. and 20 OTHERS, Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63, 883-885 (1995).
19. MATTSSON, R., MATTSSON, A., HOLMDAHL, R., SCHEYNIUS, A. and VAN DER MEIDE, P.H., In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues. Biol. Reprod., 46, 1176-1186 (1992).
20. MIZUSHIMA, S. and NAGATA, S., pEF-BOS, a powerful mammalian expression vector. Nucl. Acids Res., 18, 5322 (1990).
21. RAMARATHINAM, L., SARMA, S., MARIC, M., ZHAO, M., YANG, G., CHEN, L. and LIU, Y., Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol., 155, 5323-5329 (1995).
22. TAFURI, A., ALFERINK, J., MÖLLER, P., HÄMMERLING, G.J. and ARNOLD, B., T-cell awareness of paternal alloantigens during pregnancy. Science (Wash.), 270, 630-633 (1995).
23. TAKAHASHI, K., SHICHIJO, S., NOGUCHI, M., HIROHATA, M. and ITOH, K., Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res., 55, 3478-3482 (1995).
24. TOMITA, Y., KIMURA, M., TANIKAWA, T., NISHIYAMA, T., MORISHITA, H., TAKEDA, M., FUJIWARA, M. and SATO, S., Immunohistochemical detection of intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex class I antigens in seminoma. J. Urol., 149, 659-663 (1993).
25. UYTTENHOVE, C., MARYANSKI, J. and BOON, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. exp. Med., 157, 1040-1052 (1983).
26. VAN DEN EYNDE, B., LETHE, B., VAN PEL, A., DE PLAEN, E. and BOON, T., The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. exp. Med., 173, 1373-1384 (1991).
27. VAN DEN EYNDE, B., PEETERS, O., DE BACKER, O., GAUGLER, B., LUCAS, S. and BOON, T., A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. exp. Med., 182, 689-698 (1995).
28. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash.), 254, 1643-1647 (1991).
29. VAN SNICK, J., UYTTENHOVE, C., VAN PEL, A. and BOON, T., Stimulation of cytolytic T lymphocytes by azaguanine-resistant mouse tumor cells in selective HAT medium. J. immunol. Meth., 46, 321-326 (1981).
30. WARNIER, G., DUFFOUR, M.-T., UYTTENHOVE, C., PERRICAUDET, M., LURQUIN, C., HADDADA, H. and BOON, T., Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int. J. Cancer, 67, 303-310 (1996).